WGS of CML patients
CML patients BCR-ABL1 breakpoints were characterized through a target enrichment and NGS method using a Sure Select QXT Target Enrichment custom panel (Agilent Technologies SpA, Milano, Italy) and paired-end sequencing technologies (Hiseq2500, Illumina, IGA technology services s.r.l., Udine, Italy)